Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range <4 ng/ml - Concepedia

Concepedia

Publication | Closed Access

Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range <4 ng/ml

25

Citations

27

References

2011

Year

Kazuhiro Nagao, Y. Yamamoto, Tomohiko Hara, Hirotaka Komatsu, Rie Inoue, Kenji Matsuda, H. Matsumoto, Tomohiko Hara, Shoji Sakano, Yuki G. Baba,

Japanese Journal of Clinical Oncology

Abstract

These data could provide pathological evidence to support the suitability of the Epstein and Prostate Cancer Research International criteria. Ki67 and BUBR1 may be potential markers in selecting candidates for active surveillance.

References

	Year	Citations

Page 1